PDF) Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study
M I N I S T E R S T V O V N I T R A Č R VEŘEJNÁ VYHLÁŠKA
Mgr. Renáta Růžková – Základní škola a Mateřská škola Býchory
Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study - ScienceDirect